1. Home
  2. POLA vs GLTO Comparison

POLA vs GLTO Comparison

Compare POLA & GLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POLA
  • GLTO
  • Stock Information
  • Founded
  • POLA 1979
  • GLTO 2011
  • Country
  • POLA United States
  • GLTO Denmark
  • Employees
  • POLA N/A
  • GLTO N/A
  • Industry
  • POLA Industrial Machinery/Components
  • GLTO Biotechnology: Pharmaceutical Preparations
  • Sector
  • POLA Miscellaneous
  • GLTO Health Care
  • Exchange
  • POLA Nasdaq
  • GLTO Nasdaq
  • Market Cap
  • POLA 8.3M
  • GLTO 6.5M
  • IPO Year
  • POLA 2016
  • GLTO 2020
  • Fundamental
  • Price
  • POLA $2.83
  • GLTO $4.78
  • Analyst Decision
  • POLA
  • GLTO Buy
  • Analyst Count
  • POLA 0
  • GLTO 1
  • Target Price
  • POLA N/A
  • GLTO $10.00
  • AVG Volume (30 Days)
  • POLA 10.7K
  • GLTO 21.3K
  • Earning Date
  • POLA 11-14-2024
  • GLTO 03-07-2025
  • Dividend Yield
  • POLA N/A
  • GLTO N/A
  • EPS Growth
  • POLA N/A
  • GLTO N/A
  • EPS
  • POLA N/A
  • GLTO N/A
  • Revenue
  • POLA $14,953,000.00
  • GLTO N/A
  • Revenue This Year
  • POLA $6.72
  • GLTO N/A
  • Revenue Next Year
  • POLA N/A
  • GLTO N/A
  • P/E Ratio
  • POLA N/A
  • GLTO N/A
  • Revenue Growth
  • POLA N/A
  • GLTO N/A
  • 52 Week Low
  • POLA $2.31
  • GLTO $4.24
  • 52 Week High
  • POLA $4.90
  • GLTO $23.50
  • Technical
  • Relative Strength Index (RSI)
  • POLA 43.70
  • GLTO 45.49
  • Support Level
  • POLA $2.74
  • GLTO $4.24
  • Resistance Level
  • POLA $2.92
  • GLTO $4.65
  • Average True Range (ATR)
  • POLA 0.10
  • GLTO 0.33
  • MACD
  • POLA -0.01
  • GLTO -0.02
  • Stochastic Oscillator
  • POLA 27.42
  • GLTO 43.25

About POLA Polar Power Inc.

Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications primarily in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, Back-up DC generators, hybrid power systems, Li-Ion battery systems, and Marine DC generators. The Companie's geographical presence is in the United States, Canada, Mexico, South Pacific Islands, Japan, Europe and Middle East and Other Asia Pacific countries.

About GLTO Galecto Inc.

Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of fibrosis and impact a broad range of fibrotic and related diseases, including cancer. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.

Share on Social Networks: